Stay updated on Pembrolizumab Combo in Advanced NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Advanced NSCLC Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Advanced NSCLC Clinical Trial page
- Check3 days agoChange DetectedThe record history reflects recent updates to Study Status and Contacts/Locations for the study, along with a new version submitted on 2026-04-17. One earlier version entry (2026-04-02) was removed from the history list.SummaryDifference0.2%

- Check10 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.0%

- Check17 days agoChange DetectedThe record now shows updated Contacts/Locations and Study Status sections (version 77), reflecting current trial contacts and recruitment status.SummaryDifference0.2%

- Check24 days agoChange DetectedAdded Contacts/Locations and Study Status sections to the record (update on 2026-03-31; version 76), replacing the previous 2026-03-16 entry.SummaryDifference0.2%

- Check39 days agoChange DetectedAdded Contacts/Locations and Study Status sections. Updated the revision from v3.4.3 to v3.5.0 on 2026-03-16.SummaryDifference0.3%

- Check46 days agoChange DetectedAdded Contacts/Locations and Study Status in revision v3.4.3. The previous v3.4.2 was superseded.SummaryDifference0.3%

Stay in the know with updates to Pembrolizumab Combo in Advanced NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Advanced NSCLC Clinical Trial page.